# Ganirelix

Canonical source: https://retacompare.com/encyclopedia/ganirelix

Competitive GnRH receptor antagonist used in IVF.

Reference facts

Also known asAntagon, OrgalutranCategoryGnRH & ReproductiveMechanism of actionCompetitive GnRH receptor antagonist used in IVF.TargetsGnRH receptor (antagonist)Indications under research or approvedIVF — prevention of premature LH surgeRegulatory status (reference entry)FDA-approved (1999)Half-life~13 hoursSequence notesDecapeptide GnRH antagonist with multiple D-amino acid substitutions.Molecular weight (Da)1570Originator / sponsorOrganon / MerckFirst reported1992
    Primary References

Ganirelix FDA label


    Explore research articles about Ganirelix


    This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.

## Sources

- Ganirelix FDA label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021057s019lbl.pdf